These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 38699289)

  • 1. Use of the Chinese version of the MATRICS Consensus Cognitive Battery to assess cognitive functioning in individuals with high risk for psychosis, first-episode schizophrenia and chronic schizophrenia: a systematic review and meta-analysis.
    Cai B; Zhu Y; Liu D; Li Y; Bueber M; Yang X; Luo G; Su Y; Grivel MM; Yang LH; Qian M; Stone WS; Phillips MR
    Lancet Reg Health West Pac; 2024 Apr; 45():101016. PubMed ID: 38699289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive deficits profiles in the first-episode of schizophrenia, clinical high risk of psychosis, and genetically high-risk of psychosis.
    Dong F; Mao Z; Ding Y; Wang L; Bo Q; Li F; Wang F; Wang C
    Front Psychiatry; 2023; 14():1292141. PubMed ID: 38146278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of cognitive function in Chinese first-episode schizophrenia: MATRICS Consensus Cognitive Battery (MCCB) profile of impairment.
    Zhang H; Wang Y; Hu Y; Zhu Y; Zhang T; Wang J; Ma K; Shi C; Yu X; Li C
    Gen Psychiatr; 2019; 32(3):e100043. PubMed ID: 31423473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysfunction of Cognition Patterns Measured by MATRICS Consensus Cognitive Battery (MCCB) among First Episode Schizophrenia Patients and Their Biological Parents.
    Cao A; Shen T; Li H; Wu C; McCabe M; Mellor D; Byrne L; Zhang J; Huang J; Peng D; Xu Y
    Shanghai Arch Psychiatry; 2017 Jun; 29(3):154-160. PubMed ID: 28904510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive functioning in first-episode schizophrenia: MATRICS Consensus Cognitive Battery (MCCB) Profile of Impairment.
    McCleery A; Ventura J; Kern RS; Subotnik KL; Gretchen-Doorly D; Green MF; Hellemann GS; Nuechterlein KH
    Schizophr Res; 2014 Aug; 157(1-3):33-9. PubMed ID: 24888526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal changes in cognitive function in early psychosis: a meta-analysis with the MATRICS consensus cognitive battery (MCCB).
    Ding Y; Hou W; Wang C; Sha S; Dong F; Li X; Wang N; Lam ST; Zhou F; Wang C
    Schizophr Res; 2024 Aug; 270():349-357. PubMed ID: 38968806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profile of cognitive deficits in schizophrenia and factor structure of the Czech MATRICS Consensus Cognitive Battery.
    Bezdicek O; Michalec J; Kališová L; Kufa T; Děchtěrenko F; Chlebovcová M; Havlík F; Green MF; Nuechterlein KH
    Schizophr Res; 2020 Apr; 218():85-92. PubMed ID: 32089475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Healthy adolescent performance on the MATRICS Consensus Cognitive Battery (MCCB): Developmental data from two samples of volunteers.
    Stone WS; Mesholam-Gately RI; Giuliano AJ; Woodberry KA; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Cornblatt BA; Mathalon DH; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW; McCarley RW; Heinssen R; Green MF; Nuechterlein K; Seidman LJ
    Schizophr Res; 2016 Apr; 172(1-3):106-13. PubMed ID: 26896388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurocognitive dysfunction in subjects at clinical high risk for psychosis: A meta-analysis.
    Zheng W; Zhang QE; Cai DB; Ng CH; Ungvari GS; Ning YP; Xiang YT
    J Psychiatr Res; 2018 Aug; 103():38-45. PubMed ID: 29772485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Relationship between Cognitive Functions and Psychopathological Symptoms in First Episode Psychosis and Chronic Schizophrenia.
    Rek-Owodziń K; Tyburski E; Plichta P; Waszczuk K; Bielecki M; Wietrzyński K; Podwalski P; Rudkowski K; Michalczyk A; Grąźlewski T; Sagan L; Kucharska-Mazur J; Samochowiec J; Mak M
    J Clin Med; 2022 May; 11(9):. PubMed ID: 35566742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of cognitive impairment with quality of life and functional impairment in Ugandan first-episode psychosis patients: a cross sectional study.
    Mwesiga EK; Ssemata AS; Gumikiriza J; Nanteza A; Nakitende AJ; Nakku J; Akena D; Nakasujja N
    Health Qual Life Outcomes; 2022 Jul; 20(1):113. PubMed ID: 35870969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial aggregation of MATRICS Consensus Cognitive Battery scores in a large sample of outpatients with schizophrenia and their unaffected relatives.
    Mucci A; Galderisi S; Green MF; Nuechterlein K; Rucci P; Gibertoni D; Rossi A; Rocca P; Bertolino A; Bucci P; Hellemann G; Spisto M; Palumbo D; Aguglia E; Amodeo G; Amore M; Bellomo A; Brugnoli R; Carpiniello B; Dell'Osso L; Di Fabio F; di Giannantonio M; Di Lorenzo G; Marchesi C; Monteleone P; Montemagni C; Oldani L; Romano R; Roncone R; Stratta P; Tenconi E; Vita A; Zeppegno P; Maj M;
    Psychol Med; 2018 Jun; 48(8):1359-1366. PubMed ID: 29017620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Polish Academic Version of the MATRICS Consensus Cognitive Battery (MCCB): Evaluation of Psychometric Properties.
    Jędrasik-Styła M; Ciołkiewicz A; Styła R; Linke M; Parnowska D; Gruszka A; Denisiuk M; Jarema M; Green MF; Wichniak A
    Psychiatr Q; 2015 Sep; 86(3):435-47. PubMed ID: 25601030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The MATRICS consensus cognitive battery in patients with bipolar I disorder.
    Burdick KE; Goldberg TE; Cornblatt BA; Keefe RS; Gopin CB; Derosse P; Braga RJ; Malhotra AK
    Neuropsychopharmacology; 2011 Jul; 36(8):1587-92. PubMed ID: 21451499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive impairments in first-episode drug-naive and chronic medicated schizophrenia: MATRICS consensus cognitive battery in a Chinese Han population.
    Wu JQ; Chen DC; Tan YL; Xiu MH; De Yang F; Soares JC; Zhang XY
    Psychiatry Res; 2016 Apr; 238():196-202. PubMed ID: 27086233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modafinil for people with schizophrenia or related disorders.
    Ortiz-Orendain J; Covarrubias-Castillo SA; Vazquez-Alvarez AO; Castiello-de Obeso S; Arias Quiñones GE; Seegers M; Colunga-Lozano LE
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD008661. PubMed ID: 31828767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the MATRICS consensus cognitive battery (MCCB) to evaluate cognitive deficits in bipolar disorder: A systematic review and meta-analysis.
    Bo Q; Mao Z; Li X; Wang Z; Wang C; Ma X
    PLoS One; 2017; 12(4):e0176212. PubMed ID: 28437438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The MCCB impairment profile in a Spanish sample of patients with schizophrenia: Effects of diagnosis, age, and gender on cognitive functioning.
    Rodriguez-Jimenez R; Dompablo M; Bagney A; Santabárbara J; Aparicio AI; Torio I; Moreno-Ortega M; Lopez-Anton R; Lobo A; Kern RS; Green MF; Jimenez-Arriero MA; Santos JL; Nuechterlein KH; Palomo T
    Schizophr Res; 2015 Dec; 169(1-3):116-120. PubMed ID: 26416441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The difference of social cognitive and neurocognitive performance between patients with schizophrenia at different stages and influencing factors.
    Chen S; Liu Y; Liu D; Zhang G; Wu X
    Schizophr Res Cogn; 2021 Jun; 24():100195. PubMed ID: 33718008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.